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in any ofthe six studies cited. It is indeed a
rare epidemiologic study that has no con-
founders, much less an accumulated body
of studies. There were, in fact, significant
confounders present in most and probably
all of the studies, which the authors them-
selves described in some detail. For exam-
ple, in the three studies of welders (7-9),
there was coexposure to nickel, a known
cross-linking agent, and a variety of oxides
and metal salts. As noted by Costa et al. (7)
in their study ofwelders,
... the possible presence ofconfounding factors,
such as smoking and diet, reported to be associ-
ated with crosslinks [141 does not allow a defini-
tive conclusion.
In a preliminary report on the same
study, it was noted that "...we did observe
increased cross-linking but are unsure ofthe
agent involved" (15). Also, as noted in the
Bulgarian chrome-plater study (6),
... it is difficult to say with certainty whether the
increase in DPC was due to chromium or some
other chemical.
Confounding factors were also present in the
"environmentally exposed" populations
because their corresponding control groups
were comprised in part [NewJersey (10)] or
completely [Bulgaria (6)] ofindividuals from
rural areas with significantly less industrial
air pollution. In summary, we believe it is
somewhat overreaching to conclude that
these studies were completely free ofall con-
foundingfactors.
Second, there appear to be some con-
flicting conclusions reached in the various
studies, and we believe these warrant more
discussion than given by Zhitkovich et al.
(1). For example, in one study of welders
(7), white blood cell DPC levels were
increased over those of unexposed controls,
but there was no difference in blood chromi-
um levels between the two groups. Costa et
al. (2) assumed apriorithat Cr(VI) exposure
had occurred and suggested that DPC may
therefore be a more sensitive biomarker than
blood chromium concentrations. However,
in the Bulgarian chrome platers (6), blood
chromium levels were significantly elevated
(almost 10-fold) above controls, a clear
indication that chromium exposure had
occurred; yet there was no difference in
DPC levels in the exposed group versus the
control group. These findings are directly
contradictory: DPC was elevated in workers
with negative evidence of Cr(VI) exposure,
and DPC was not elevated in workers with
clear evidence of Cr(VI) exposure. The
findings related to the `environmentally
exposed" groups are also inconsistent. For
example, Table 1 presented by Zhitkovich
et al. (1) indicates that Zhitkovich et al.
(16) measured elevated DPC in a Bulgarian
population (residents ofJambol) that expe-
rienced environmental Cr(VI) exposure.
However, Zhitkovich et al. (16) did not
measure environmental Cr(VI) levels in
Jambol. They simply concluded that the
Jambol residents must have been exposed to
Cr(VI) because their mean blood chromium
level was higher than in residents from
another town (Burgas). Yet this assumption
is internally inconsistent with the fact that
Costa et al. (6) found no difference in DPC
levels between the chrome platers and the
Jambol residents, two groups with tremen-
dous differences in blood chromium levels.
Other such inconsistencies can be found,
and as a result we do not believe the epi-
demiologic evidence is yet sufflicient to con-
clude that DPC is a proven biomarker for
Cr(VI) exposure.
We believe that a simple, rapid, and
reliable biomarker for screening or quanti-
tating Cr(VI) exposure would be a very
valuable tool. For this reason we suggest
that the technical underpinnings of any
proposed Cr(VI) biomarker merits rigorous
evaluation before its acceptance as an accu-
rate technique. Clearly more work should
be done regarding the use ofDPC to char-
acterize exposure to Cr(VI).
DennisJ. Paustenbach
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Dietary Exposure to PCBs
and Dioxins
We read with great interest the paper by
Patandin et al. (1) in which they describe
their efforts to model dietary intake ofcer-
tain highly lipophilic compounds (poly-
chlorinated biphenyls and dioxins) over the
first 25 years of life. In the context of
exploring distributional dosimetry ofbreast
milk contaminants to nursing children (2),
we were particularly interested in the por-
tion of the model that addressed intake to
nursing infants. As a prerequisite of assess-
ing potential adverse health effects, this
information should be extended to estimate
the resulting tissue concentrations.
For estimating tissue concentrations as a
function of age, intake is one of many fac-
tors. Other factors that must be taken into
account include organ and tissue volumes, as
well as elimination parameters and their
respective changes over time. Elimination of
this dass oflipophilic compounds from the
body should reflect both fecal excretion of
the unchanged compound and metabolism
occurring mainly in the liver. Because liver
and tissue volumes, as well as mass offeces,
change drastically during growth, elimina-
tion parameters (represented by half-lives)
cannot be time-independent constants in
the range of several years, as is usually
assumed. A reduced apparent half-life of
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such compounds has been described in
infants (3) and in offspring of rhesus mon-
keys (4), as exemplified by 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD). For
example, the half-life for nonmetabolic
elimination ofTCDD has been calculated
to be 0.42 years in newborns, which is sub-
stantially shorter than in adults (3). From
TCDD data collected over more than 15
years following the Seveso incident (5), it is
obvious that the half-life is shorter in infants
and increases significantly with age.
Although the amount ofTCDD in the
organism is a function ofuptake and elimi-
nation, the resulting tissue concentrations
are also functions of the body and tissue
volumes. The fast growth in the first years
of life leads to a "thinning" of the TCDD
tissue concentrations (3,6). Although the
relatively fast half-life, together with the
"thinning" effect, are insufficient to prevent
an increase ofTCDD tissue concentrations
during nursing, after weaning, both growth-
related dilution and elimination from the
body result in a fast decrease in these con-
centrations. In fact, TCDD concentrations
in tissues of babies breast-fed for up to 6
months can reach values in the lower range
of adults, but the concentrations decline
rather quickly, reaching values comparable
to nonbreast-fed children at about 5 years of
age (3). Importantly, these results are based
on general assumptions related to the class
ofcompounds described as lipophilic, non-
water soluble, nonvolatile, nonprotein
bound, and either slowly metabolized or not
metabolized; therefore, these results should
be valid not only for TCDD but for all
compounds meeting this description (3).
In conclusion, based on the current sci-
entific literature, even relatively high TCDD
concentrations that might be reached after 6
months ofnursing do not appear to lead to a
raised lifetimevalue. Comparing intake from
breast-feeding with cumulative long-term
intake may result in misleading perceptions
about health risks associated with intake of
TCDD and congeners.
JudyS. LaKind
LaKind Associates, LLC
Catonsville, Maryland
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Patandin's Response
We would like to respond to LaKind and
Filser's comments about our paper that
was published in EHP(1).
LaKind and Filser emphasized that tis-
sue concentrations of TCDD and related
compounds are important when assessing
potential adverse effects, rather than assess-
ing long-term dietary intake only. We
agree with them; however, long-term
dietary intake is an important part ofexpo-
sure assessment. In our paper we mainly
focused on the polychlorinated biphenyl
(PCB) and dioxin (polychlorinated diben-
zodioxin and furan; PCDD/PCDF) intake
during different periods in life. Over 90%
ofexposure to PCBs and dioxins in the gen-
eral population is from oral intake. We
compared the intake of toxic equivalents
(TEQs) during breast-feeding (0-1 year of
age), after weaning (e.g., preschool years;
1-5 years of age), and until adulthood
(6-25 years ofage). We also calculated the
amount (percentage) of PCB/dioxin TEQ
intake during a 6-month period of breast-
feeding and its effect on the total cumula-
tive intake until adulthood (25 years).
Although some model calculations of
PCB/dioxin body burden and infant expo-
sure through breast milk have been pub-
lished (2,3), the cumulated PCB/dioxin
intake from infancy until adulthood had not
been quantitatively assessed. The cumulated
intake as calculated in this study is not iden-
tical to body burden because losses by excre-
tion and metabolism by the liver, as well as
different half-lives of different PCB and
dioxin congeners, are not taken into account
(1). We calculated the total mean intake of
PCBs/dioxins over a 25-year period in sub-
jects who were either formula-fed or breast-
fed for 3 and 6 months duringinfancy.
LaKind and Filser emphasized the thin-
ning effect in infants during growth and
the shorter half-lives reported for TCDD in
infants. The dilution effect of PCBs and
dioxins in the growing infant is a known
phenomenon (4,5). This dilution effect is
also found in older adults when the increase
ofPCB/dioxin tissue concentration is lower
than expected because of the increase of
total body fatwith age (2).
In aprevious publication (6), we present-
ed the sum PCB levels (IUPAC numbers
118, 138, 153, and 180) measured in the
plasma of42-month-old children who were
eitherbreast-fed orformula-fedduringinfan-
cy. The PCB levels measured at 42 months
ofage were strongly related (r= 0.63) to the
period ofbreast-feeding and negatively asso-
ciated with total body fat (percentage) and
body weight. Preschool children who were
breast-fed as infants have PCB body burdens
that are primarily dictated bytheir lactational
PCB exposures. The negative relationship
with plasma PCB concentration and body
fat percentage is most likely explained by the
fact that PCBs and related compounds are
distributed over all fat-containing compo-
nents in the body, especially adipose tissue
(diluted). Given a higher growth rate as well
as this dilution effect, a shorter half-life has
been reported for PCBs and dioxins in
young children (4,5). Despite this rapid
growth and shorter half-life, breast-fed
infants reach PCB and dioxin levels as high
as their mothers (adults) (6).
According to LaKind and Filser, the high
TCDD tissue concentration after 6 months
ofbreast-feeding does not give an increased
lifetime value for TCDD body burden. This
still needs to be investigated more thorough-
ly. Model calculations presented by Ayotte
(7) show that body burden in breast-fed
infants are relevant for the childhood years,
but not for periods beyond 20-30 years of
age. However, Smith (8) suggested that an
infant breast-fed for 12 months would
receive approximately 10% ofthe cumulative
exposure dose per bodyweight thatwould be
received by an adult with 50 years ofexpo-
sure. During childhood, the body burden is
raised by lactational PCB/dioxin exposure
(3,6). At 25 years of age, the PCB/dioxin
body burden could be higher due to breast-
feeding for 6 months. We reported (1) that 6
months ofbreast-feeding contributes to over
10% of the cumulative dietary intake until
25 years ofage. This amount ofPCB/dioxin
intake during 6 months ofbreast-feeding is
not negligible and certainly will not result in
misleading perceptions about health risk
assessment. In this paper (1), we tried to give
more quantitative information about the
dietary intake and several bodyburden calcu-
lations. We want to emphasize that although
PCB/dioxin accumulation in the infant's
body is a disadvantage, there are numerous
advantages ofbreast-feeding on the general
development ofinfants; therefore, we do not
encourage shortening the lactation period in
the general population (1,9).
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